eHealth Initiative launches 2020 Roadmap

The eHealth Initiative launched a new public-private collaboration--the 2020--Roadmap, to help guide the transformation of the U.S. healthcare system by 2020.

To be developed over the next six months through a series of surveys, webinars, executive roundtables and events with key constituents, 2020 Roadmap will propose key policy recommendations to implement at a federal level and actions for the private sector to help transform healthcare. These recommendations will focus on:

  • Identifying a sustainable glide path for Meaningful Use
  • Promoting interoperable systems
  • Transforming care delivery
  • Balancing innovation and privacy

“Health reform calls for transformation to a value-based interoperable system, but there is little direction on how to transition from our current work processes and systems. Clinicians, payers and providers need leadership to help transform delivery systems and control cost,” said Jennifer Covich Bordenick, CEO of the eHealth Initiative, in a statement. “The goal of our new initiative is to craft a multi-stakeholder solution that coordinates the efforts of both the public and private sector so that we can make this transition successfully.”

Visit the 2020 Roadmap website for more information.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.